Cardiomyopathy

Clinical Trial Finder

Many patients with cardiomyopathy are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Multicentre Investigation of Novel Electrocardiogram Risk Markers in Ventricular Arrhythmia Prediction

Conditions:   Ventricular Arrythmia;   Ischemic Cardiomyopathy
Intervention:  
Sponsor:   University of Leicester
Recruiting - verified November 2016

Semmelweis Sport Study

Condition:   Athletes Heart
Intervention:  
Sponsors:   Semmelweis University Heart and Vascular Center;   National Research, Development and Innovation Office (NKFIH) of Hungary (K 120277).
Recruiting - verified January 2017

Cohort Description of Younger With AV-block

Conditions:   Atrioventricular Block;   Progressive Cardiac Conduction Defect;   Genetic Disease
Intervention:   Device: Pacemaker
Sponsor:   University of Aarhus
Not yet recruiting - verified January 2017

HeartMate 3 CE Mark Study Long Term Follow-up

Condition:   Advanced Refractory Left Ventricular Heart Failure
Intervention:   Other: Long term follow-up
Sponsor:   St. Jude Medical
Recruiting - verified January 2017

Impact of Hemodynamic Ramp Test-Guided HVAD RPM and Medication Adjustments on Exercise Tolerance and Quality of Life

Condition:   Continous Flow Left Ventricular Device
Interventions:   Procedure: Echo Guided Testing;   Procedure: Hemodynamic-Echo Ramp Testing -
Sponsor:   University of Chicago
Recruiting - verified January 2017

Annular Contraction for Transcatheter Treatment of Insufficient Mitral ValvE

Conditions:   Mitral Valve Insufficiency;   Cardiac Valve Annuloplasty;   Mitral Valve Annuloplasty;   Cardiovascular Diseases;   Heart Diseases;   Heart Valve Diseases;   Mitral Regurgitation
Intervention:   Device: Cardioband Mitral System
Sponsor:   Valtech Cardio Ltd
Not yet recruiting - verified January 2017

Anakinra Versus Placebo for the Treatment of Acute MyocarditIS

Condition:   Acute Myocarditis
Interventions:   Drug: ANAKINRA 100 mg/daily subcutaneously;   Drug: Placebo
Sponsor:   Assistance Publique - Hôpitaux de Paris
Not yet recruiting - verified January 2017

Treating Heart Failure With Enhanced External Counterpulsation (EECP)

Condition:   Heart Failure
Intervention:  
Sponsor:   Charite University, Berlin, Germany
Recruiting - verified January 2017

Myocardial Work and Metabolism in CRT

Conditions:   Left Ventricular Dyssynchrony;   Heart Failure;   Left Bundle Branch Block;   Cardiomyopathy
Interventions:   Device: Cardiac resynchronisation therapy;   Other: Echocardiography;   Other: Magnetic Resonance Imaging;   Other: Positron Emission Tomography
Sponsors:   Universitaire Ziekenhuizen Leuven;   Oslo University Hospital
Recruiting - verified January 2017

A Rollover Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy

Condition:   LMNA-Related Dilated Cardiomyopathy
Intervention:   Drug: ARRY-371797, p38 inhibitor, oral
Sponsor:   Array BioPharma
Recruiting - verified January 2017

Budapest Upgrade CRT Study (Version 009-4.1)

Condition:   Cardiomyopathy
Intervention:   Device: CRT-D
Sponsors:   Semmelweis University Heart and Vascular Center;   University of Rochester;   Sheba Medical Center;   Pharmahungary Group
Enrolling by invitation - verified January 2017

18F-deoxyglucose (FDG) PET-CMD

Condition:   Patients With Idiopathic Dilated Cardiomyopathy
Intervention:   Drug: 18F-deoxyglucose (FDG)
Sponsor:   Nantes University Hospital
Active, not recruiting - verified January 2017

Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy

Condition:   Transthyretin (TTR) Amyloid Cardiomyopathy
Interventions:   Drug: Tafamidis;   Drug: Tafamidis;   Drug: Placebo
Sponsor:   Pfizer
Active, not recruiting - verified January 2017

Heart and Muscle Metabolism in Barth Syndrome

Condition:   Barth Syndrome
Intervention:  
Sponsors:   Washington University School of Medicine;   University of Florida
Recruiting - verified January 2017

IMAGE-HF Project I-A: Cardiac Imaging in Ischemic Heart Failure (AIMI-HF)

Conditions:   Heart Failure;   Coronary Artery Disease;   Ischemic Cardiomyopathy;   Non-ischemic Cardiomyopathy
Interventions:   Other: Advanced cardiac imaging;   Other: Standard Cardiac Imaging
Sponsors:   Ottawa Heart Institute Research Corporation;   Canadian Institutes of Health Research (CIHR);   The Finnish Funding Agency for Technology and Innovation (TEKES)
Recruiting - verified January 2017

This is a Study to Get More Information About Non Ambulatory Boys & Men With Duchenne Muscular Dystrophy

Condition:   Duchenne Muscular Dystrophy
Intervention:  
Sponsors:   Washington University School of Medicine;   Nationwide Children's Hospital;   Boston Children’s Hospital;   University of Minnesota - Clinical and Translational Science Institute;   University of California, Davis
Completed - verified January 2017

Safety And Efficacy Evaluation Of Fx-1006a In Patients With V122i Or Wild-Type Transthyretin (TTR) Amyloid Cardiomyopathy

Condition:   TTR-CM
Intervention:   Drug: tafamidis
Sponsor:   Pfizer
Active, not recruiting - verified January 2017

The SMARTEX Heart Failure Study

Condition:   Heart Failure
Interventions:   Behavioral: high-intensity interval training;   Behavioral: Moderate continuous training;   Behavioral: Recommendation of regular moderate exercise
Sponsors:   Norwegian University of Science and Technology;   University Hospital, Antwerp;   UMC Utrecht;   Technische Universität München;   Heartcenter Leipzig GmbH;   Bispebjerg Hospital;   St. Olavs Hospital;   Helse Stavanger HF;   Scientific Institute of Veruno;   Centre Hospitalier du Luxembourg;   Alesund Hospital;   Levanger Hospital
Completed - verified November 2016